Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

2

5-Star Stocks Poised to Pop: Novartis

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Swiss pharmaceutical giant Novartis (NYSE: NVS  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Novartis' business and see what CAPS investors are saying about the stock right now.

Novartis facts

Headquarters (Founded) Basel, Switzerland (1895)
Market Cap $137 billion
Industry Pharmaceuticals
Trailing-12-Month Revenue $58.8 billion
Management CEO Joseph Jimenez
CFO Jonathan Symonds
Return on Equity (Average, Past 3 Years) 15.7%
Cash/Debt $5.6 billion / $23.9 billion
Dividend Yield 4.1%
Competitors Merck (NYSE: MRK  )
Pfizer (NYSE: PFE  )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 1,522 members who have rated Novartis believe the stock will outperform the S&P 500 going forward. These bulls include All-Stars clayman14 and starbucks4ever, both of whom are ranked in the top 10% of our community.    

A few months ago, clayman14 succinctly summed up the Novartis bull case: "Swiss Compan[y] + Decent Yield + Pharma."

Over the past five years, Novartis has even grown its bottom line at a solid rate of 8% annually. That's faster than other drug behemoths like Merck (-4%), Pfizer (-2%), and Johnson & Johnson (NYSE: JNJ  ) (1%).

CAPS All-Star starbucks4ever expands on the Novartis outperform argument:

A reasonably safe bet. [M]anagement is finished destroying value through acquisitions. ... That leaves us with a low [price-to-earnings multiple], and with speculators assuming … that with no more empire building the [earnings] will finally accrue to them. This illusion will put a floor under the price, especially when the [earnings are] stable and speculators are desperately looking for stability.

What do you think about Novartis, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.  

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Novartis, Pfizer, and Johnson & Johnson, as well as creating a diagonal call position in Johnson & Johnson. The Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1749897, ~/Articles/ArticleHandler.aspx, 5/28/2012 12:13:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:01 PM
NVS $51.96 Up +0.23 +0.44%
Novartis CAPS Rating: *****
PFE $22.13 Down -0.01 -0.05%
Pfizer, Inc. CAPS Rating: ****
MRK $37.55 Down -0.05 -0.13%
Merck & Co., Inc. CAPS Rating: ****
JNJ $62.51 Down -0.59 -0.94%
Johnson & Johnson CAPS Rating: *****

Advertisement